Found: 5
Select item for more details and to access through your institution.
Evaluation of the protective efficacy of a Leishmania protein associated with distinct adjuvants against visceral leishmaniasis and in vitro immunogenicity in human cells.
- Published in:
- Parasitology Research, 2020, v. 119, n. 8, p. 2609, doi. 10.1007/s00436-020-06752-x
- By:
- Publication type:
- Article
Liposomal Formulation of ChimeraT, a Multiple T-Cell Epitope-Containing Recombinant Protein, Is a Candidate Vaccine for Human Visceral Leishmaniasis.
- Published in:
- Vaccines, 2020, v. 8, n. 2, p. 289, doi. 10.3390/vaccines8020289
- By:
- Publication type:
- Article
Parasitological and immunological evaluation of a novel chemotherapeutic agent against visceral leishmaniasis.
- Published in:
- Parasite Immunology, 2020, v. 42, n. 12, p. 1, doi. 10.1111/pim.12784
- By:
- Publication type:
- Article
A candidate vaccine for human visceral leishmaniasis based on a specific T cell epitope-containing chimeric protein protects mice against Leishmania infantum infection.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. 1, doi. 10.1038/s41541-020-00224-0
- By:
- Publication type:
- Article
A clioquinol-containing Pluronic<sup>®</sup> F127 polymeric micelle system is effective in the treatment of visceral leishmaniasis in a murine model.
- Published in:
- Parasite (1252607X), 2020, v. 27, p. 1, doi. 10.1051/parasite/2020027
- By:
- Publication type:
- Article